lobbying_activities: 748461

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
748461	563cb106-b79e-4569-bc1e-b24c9eab57dc	1T	THE WERNER GROUP	298557	SHIRE PHARMACEUTICALS	2009	first_quarter	MED	HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues	HOUSE OF REPRESENTATIVES,SENATE	20000		0	1	2009-04-14T11:09:57-04:00